How pancreatic cancer cells dodge drug treatments ...Middle East

- News
How pancreatic cancer cells dodge drug treatments
Pancreatic cancer cells typically rely on a mutant version of the KRAS protein to proliferate. These cancer cells can also survive losing KRAS by activating alternative growth pathways. CSHL scientists discovered a new interaction between mutant KRAS and a protein complex called RSK1/NF1 that may be the source of this adaptive resistance.

Hence then, the article about how pancreatic cancer cells dodge drug treatments was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( How pancreatic cancer cells dodge drug treatments )

Apple Storegoogle play

Last updated :

Also on site :